Published in J Exp Med on January 20, 1997
Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J Exp Med (2000) 2.18
Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse. Nat Immunol (2005) 1.85
Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy. J Exp Med (1999) 1.37
Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med (2008) 1.27
Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement. J Immunol (2003) 1.27
Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering. J Exp Med (1997) 1.26
Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. Eur J Immunol (2007) 1.24
Differential T-cell antigen receptor signaling mediated by the Src family kinases Lck and Fyn. Mol Cell Biol (2000) 1.17
Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor. J Exp Med (1998) 1.16
CD8 controls T cell cross-reactivity. J Immunol (2010) 1.15
Glucocorticoids attenuate T cell receptor signaling. J Exp Med (2001) 1.10
NSOM/QD-based direct visualization of CD3-induced and CD28-enhanced nanospatial coclustering of TCR and coreceptor in nanodomains in T cell activation. PLoS One (2009) 1.01
Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor. J Exp Med (1998) 1.00
A role for CD8 in the developmental tuning of antigen recognition and CD3 conformational change. J Immunol (2008) 0.97
CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions. Eur J Immunol (2007) 0.96
Phenotypic models of T cell activation. Nat Rev Immunol (2014) 0.94
The molecular determinants of CD8 co-receptor function. Immunology (2012) 0.94
Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor alpha chain. J Exp Med (1998) 0.93
CD3 ligation on immature thymocytes generates antagonist-like signals appropriate for CD8 lineage commitment, independently of T cell receptor specificity. J Exp Med (1998) 0.88
Activation of macrophages and interference with CD4+ T-cell stimulation by Mycobacterium avium subspecies paratuberculosis and Mycobacterium avium subspecies avium. Immunology (2003) 0.86
Decreased CD4 expression by polarized T helper 2 cells contributes to suboptimal TCR-induced phosphorylation and reduced Ca2+ signaling. Eur J Immunol (2005) 0.85
Role of CD8 in aberrant function of cytotoxic T lymphocytes. J Exp Med (1997) 0.82
The coreceptor CD4 is expressed in distinct nanoclusters and does not colocalize with T-cell receptor and active protein tyrosine kinase p56lck. Proc Natl Acad Sci U S A (2015) 0.81
An antagonist peptide mediates positive selection and CD4 lineage commitment of MHC class II-restricted T cells in the absence of CD4. J Exp Med (2005) 0.81
Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage. J Exp Med (1998) 0.81
Thymocyte apoptosis. J Clin Immunol (1999) 0.81
Structure-Function analysis of the CTLA-4 interaction with PP2A. BMC Immunol (2009) 0.80
Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8. J Immunol (2011) 0.80
Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide. Proc Natl Acad Sci U S A (1998) 0.79
Single cell analysis of cytokine expression kinetics by human CD4+ T-cell clones during activation or tolerance induction. Immunology (2000) 0.76
Molecular requirements for T cell recognition by a major histocompatibility complex class II-restricted T cell receptor: the involvement of the fourth hypervariable loop of the Valpha domain. J Exp Med (1999) 0.75
Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cues. JCI Insight (2016) 0.75
Suboptimal T-cell receptor signaling compromises protein translation, ribosome biogenesis, and proliferation of mouse CD8 T cells. Proc Natl Acad Sci U S A (2017) 0.75
Signal transduction by receptors with tyrosine kinase activity. Cell (1990) 22.72
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol (1983) 14.36
The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell (1988) 10.47
Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol (1980) 8.56
Evidence for a differential avidity model of T cell selection in the thymus. Cell (1994) 5.24
Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature (1987) 5.24
Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck. Nature (1989) 5.20
Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci U S A (1995) 5.01
"Infectious" transplantation tolerance. Science (1993) 4.98
T-cell-receptor affinity and thymocyte positive selection. Nature (1996) 4.96
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (1993) 3.83
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell (1994) 3.71
Signals and signs for lymphocyte responses. Cell (1994) 3.66
Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol (1996) 3.59
Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (1991) 3.58
Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (1995) 3.40
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell (1992) 3.24
Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today (1993) 2.91
Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science (1994) 2.86
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity (1996) 2.69
Expression and function of the CD3-antigen receptor on murine CD4+8+ thymocytes. Nature (1987) 2.38
The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol (1992) 2.34
Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature (1988) 2.25
CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature (1995) 2.15
Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature (1991) 2.15
Evidence for a physical association of CD4 and the CD3:alpha:beta T-cell receptor. Nature (1987) 2.01
Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature (1992) 1.98
MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature (1992) 1.95
Essential flexibility in the T-cell recognition of antigen. Nature (1996) 1.86
T cell receptor antagonists and partial agonists. Immunity (1995) 1.83
Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity (1995) 1.83
Specificity and flexibility in thymic selection. Nature (1994) 1.72
T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance. J Immunol (1985) 1.66
Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity (1996) 1.64
Clonal analysis of the major histocompatibility complex restriction and the fine specificity of antigen recognition in the T cell proliferative response to cytochrome C. J Immunol (1983) 1.63
T-cell development. Accessories or coreceptors? Nature (1988) 1.56
The level of CD8 expression can determine the outcome of thymic selection. Cell (1992) 1.53
Ligands for the T-cell receptor: hard times for avidity models. Immunol Today (1995) 1.46
The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal. J Mol Cell Immunol (1986) 1.45
Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4. Eur J Immunol (1987) 1.43
Partial signaling by CD8+ T cells in response to antagonist ligands. J Exp Med (1996) 1.41
Formation of a bispecific antibody by the use of leucine zippers. J Immunol (1992) 1.37
Functionally distinct subsites on a class II major histocompatibility complex molecule. Nature (1987) 1.36
T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen. J Exp Med (1993) 1.31
Physical association of CD4 with the T cell receptor. J Immunol (1992) 1.28
Comodulation of CD3 and CD4. Evidence for a specific association between CD4 and approximately 5% of the CD3:T cell receptor complexes on helper T lymphocytes. J Immunol (1988) 1.28
Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc Natl Acad Sci U S A (1993) 1.21
Structural requirements for enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Mol Cell Biol (1992) 1.20
Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J Exp Med (1994) 1.19
Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. Semin Immunol (1996) 1.15
Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity (1994) 1.10
Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol (1994) 1.09
Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation (1992) 1.08
Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J Exp Med (1995) 1.06
Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc Natl Acad Sci U S A (1995) 1.05
Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J Exp Med (1991) 1.03
Endogenous altered peptide ligands can affect peripheral T cell responses. J Exp Med (1996) 1.01
The role of the murine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies. J Mol Cell Immunol (1987) 0.98
The ligand for positive selection of T lymphocytes in the thymus. Curr Opin Immunol (1994) 0.96
The co-receptor function of CD4. Semin Immunol (1991) 0.95
The L3T4 molecule is part of the helper T-cell antigen/Ia recognition complex. Ann Inst Pasteur Immunol (1987) 0.90
Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands. J Immunol (1996) 0.89
High fives or hand clasps? Curr Biol (1992) 0.87
Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules. Immunol Today (1995) 0.87
Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A (1995) 0.85
The use of monoclonal antibodies to achieve immunological tolerance. Immunol Today (1993) 0.85
The structural basis of CD4-MHC class II interactions: coreceptor contributions to T cell receptor antigen recognition and oligomerization-dependent signal transduction. Curr Top Microbiol Immunol (1996) 0.84
Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult. Immunol Rev (1992) 0.83
Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade. Transplantation (1994) 0.83
Evidence that clonal anergy is induced in thymic migrant cells after anti-CD4-mediated transplantation tolerance. Transplantation (1993) 0.80
The role of CD4/L3T4 in T-lymphocyte function. Ann Inst Pasteur Immunol (1987) 0.77
The Ensembl genome database project. Nucleic Acids Res (2002) 40.87
Ensembl 2009. Nucleic Acids Res (2008) 25.38
Ensembl 2008. Nucleic Acids Res (2007) 20.67
Ensembl 2007. Nucleic Acids Res (2006) 20.10
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity (2000) 15.44
Ensembl 2005. Nucleic Acids Res (2005) 15.13
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity (1995) 14.90
Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A (1987) 14.24
Ensembl 2002: accommodating comparative genomics. Nucleic Acids Res (2003) 12.26
Ensembl 2004. Nucleic Acids Res (2004) 11.88
Ensembl 2006. Nucleic Acids Res (2006) 11.66
CD28/B7 system of T cell costimulation. Annu Rev Immunol (1996) 10.48
CTLA-4 can function as a negative regulator of T cell activation. Immunity (1994) 9.80
Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol (2001) 6.68
In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med (1997) 6.53
Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol (2000) 6.46
The B7 and CD28 receptor families. Immunol Today (1994) 6.38
RANK is essential for osteoclast and lymph node development. Genes Dev (1999) 5.85
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis (1994) 5.44
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity (1997) 5.44
Redesigning health care. BMJ (2001) 5.43
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science (1992) 5.36
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood (2000) 5.06
Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol (2001) 4.99
CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med (1996) 4.97
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83
An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1988) 4.72
IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol (1993) 4.65
Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature (1984) 4.28
Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol (1994) 4.27
TB policy and the badger culling trials. Vet Rec (2006) 4.14
Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med (2000) 4.14
Immunology. The ins and outs of antigen processing and presentation. Nature (1986) 4.08
The clinical and laboratory diagnosis of Trichomonas vaginalis infection. Sex Transm Dis (1981) 3.89
A single major pathway of T-lymphocyte interactions in antigen-specific immune suppression. Scand J Immunol (1981) 3.85
TB policy and the badger culling trials. Vet Rec (2006) 3.84
The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry (1990) 3.75
Systematic review of multidisciplinary interventions in heart failure. Heart (2005) 3.68
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67
Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. Proc Natl Acad Sci U S A (1983) 3.66
The immune response genes of the major histocompatibility complex. Immunol Rev (1978) 3.61
Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol (2001) 3.53
The "redisorganisation" of the NHS. BMJ (2001) 3.52
Effect of low-level body burdens of lead on the mental development of children: limitations of meta-analysis in a review of longitudinal data. Arch Environ Health (1992) 3.42
Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (1995) 3.40
A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice. J Exp Med (1992) 3.37
Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect (2004) 3.27
CTLA-4: a negative regulator of autoimmune disease. J Exp Med (1996) 3.25
Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors. J Exp Med (1980) 3.21
Cervical screening in Perth and Kinross since introduction of the new contract. BMJ (1991) 3.20
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med (1995) 3.18
A low resolution structure for the histone core of the nucleosome. Nature (1980) 3.17
Suppressor T cells--they're back and critical for regulation of autoimmunity! Immunol Rev (2001) 3.16
Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature (1990) 3.15
Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg (1995) 3.08
Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J Immunol (1995) 3.06
Public health gets a boost in NHS streamlining. BMJ (1994) 3.03
Molecular basis of T cell inactivation by CTLA-4. Science (1998) 3.00
WEIL'S DISEASE (LEPTOSPIROSIS): A CLINICAL AND BACTERIOLOGICAL STUDY OF NINETEEN CASES OCCURRING CHIEFLY AMONG FISH WORKERS. Br Med J (1934) 2.99
The dynamics of chromosome evolution in birds and mammals. Nature (1999) 2.95
Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet (1998) 2.90
Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol (1997) 2.89
Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr (1983) 2.89
Women prefer hospital births. BMJ (1992) 2.88
Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med (1998) 2.84
Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology (1998) 2.81
Major histocompatibility complex-linked specificity of gamma delta receptor-bearing T lymphocytes. Nature (1987) 2.81
The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med (2000) 2.80
Competing demands from physical problems: effect on initiating and completing depression care over 6 months. Arch Fam Med (2001) 2.77
MvirDB--a microbial database of protein toxins, virulence factors and antibiotic resistance genes for bio-defence applications. Nucleic Acids Res (2006) 2.76
The role of competing demands in the treatment provided primary care patients with major depression. Arch Fam Med (2000) 2.75
Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol (2000) 2.70
Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis (1997) 2.65
Results of provider self-adjudication using the prudent layperson standard compared with the managed care organization's emergency department claim review process. Ann Emerg Med (2000) 2.64
The nature of major histocompatibility complex recognition by gamma delta T cells. Cell (1994) 2.64
Kinetic tuning of myosin via a flexible loop adjacent to the nucleotide binding pocket. J Biol Chem (1998) 2.62
The purified yeast pre-mRNA splicing factor PRP2 is an RNA-dependent NTPase. EMBO J (1992) 2.60
Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am J Surg Pathol (1996) 2.60
London's health care again. BMJ (1992) 2.56
Improving depression outcomes in community primary care practice: a randomized trial of the quEST intervention. Quality Enhancement by Strategic Teaming. J Gen Intern Med (2001) 2.56
Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J Exp Med (1986) 2.55
A novel lymphocyte function-associated antigen (LFA-1): cellular distribution, quantitative expression, and structure. J Immunol (1981) 2.52
Shared idiotypic determinants on antibodies and T-cell-derived suppressor factor specific for the random terpolymer L-glutamic acid60-L-alanine30-L-tyrosine10. J Exp Med (1979) 2.51
Improving London's health service. BMJ (1993) 2.50
Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr (1982) 2.41
Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ (1997) 2.41
Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells. J Exp Med (1979) 2.40
Characterization of T cell receptor gamma chain expression in a subset of murine thymocytes. Science (1986) 2.40
A role for peptide in determining MHC class II structure. Nature (1991) 2.32
A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science (1989) 2.32
Absence of B7-dependent responses in CD28-deficient mice. Immunity (1994) 2.32
Medical students' clinical self-assessments: comparisons with external measures of performance and the students' self-assessments of overall performance and effort. Acad Med (1993) 2.30
Gift authorship: a poisoned chalice? BMJ (1994) 2.30
Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J Exp Med (1993) 2.27
Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med (2000) 2.25
Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med (1995) 2.24
Dominance in lambda S mutations and evidence for translational control. J Mol Biol (1988) 2.24
NHS reorganisation. Cause and effect. Health Serv J (2001) 2.23